Stay updated on ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating the study record is not accessible. The usual study content and navigation are replaced by an error screen and site footer.
    Difference
    17%
    Check dated 2026-09-19T22:10:08.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.6.6 appears on the page, replacing Revision: v3.6.5. This is a minor build/update to the site interface and does not affect the trial information or user actions.
    Difference
    0.1%
    Check dated 2026-08-29T20:59:41.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.6.5 is now displayed on the page, replacing the previous v3.6.4. This indicates a site version update that does not modify the study content or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-08-08T19:17:22.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The website version was updated from v3.6.3 to v3.6.4, representing a maintenance/patch release. This change does not modify the study content or data shown on the page.
    Difference
    0.1%
    Check dated 2026-07-25T11:52:36.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3, indicating an underlying platform version bump. This appears to be a software update behind the scenes rather than a change to the study page content.
    Difference
    0.1%
    Check dated 2026-07-03T23:51:58.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.0 to v3.6.2, indicating a backend/software update. The study details and user-facing content remain unchanged.
    Difference
    0.1%
    Check dated 2026-06-26T20:48:33.000Z thumbnail image

Stay in the know with updates to ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page.